Skip to content

Clinical trials

Phase 1 Blood Coagulation Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Coagulation Disorders Phase: Phase 1 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20121
20131
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.2
Hutchmed1
Nova Scotia Health Authority1
Queen's University1
Swedish Orphan Biovitrum1
Technical University of Munich1
TiumBio Co., Ltd.1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Coagulation Disorders9
Hematologic Diseases3
Hemorrhagic Disorders3
Hemostatic Disorders3
Hemophilia A2
Immunoproliferative Disorders2
Lymphoproliferative Disorders2
Multiple Myeloma2
Paraproteinemias2
Pathologic Processes2

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.